SHORT REPORTSChronic neurodegenerative disease associated with HTLV-II infection
References (9)
- et al.
HTLV-II in patients with HTLV-I-associated myelopathy
Lancet
(1991) - et al.
HTLV-II and HTLV-I associated myelopathy
Lancet
(1991) Human T-cell leukemia/lymphoma viruses: life cycle, pathogenicity, epidemiology and diagnosis
Arch Pathol Lab Med
(1991)- et al.
Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II
Neurology
(1991)
Cited by (249)
Detection of early phase human T-cell leukemia virus type 1 and 2 infection with an improved confirmatory test
2023, Journal of Clinical VirologyPathogenesis of HTLV-1 infection and progression biomarkers: An overview
2021, Brazilian Journal of Infectious DiseasesCitation Excerpt :Although the frequency of unfavorable clinical outcomes of HTLV-1 infections is considered low (5-10%), HTLV-1 infection may be associated with other clinical processes that need to be better defined. [102–104]. The increased frequency of reports of diseases associated with HTLV-2 [3,94,105–111] requires attention to rule out the participation of HTLV-2 in clinical outcomes, especially in areas endemic for this virus [112]. HTLV-1 induces a persistent chronic infection.
HTLV-I and Strongyloides in Australia: The worm lurking beneath
2021, Advances in ParasitologyCitation Excerpt :A third type, HTLV-III, often referred to in earlier articles as the causative agent of AIDS, is now recognized as the human immunodeficiency virus (HIV) (Abe, 1986; Bayley et al., 1985). HTLV-II is considered less pathogenic than HTLV-I and is rarely associated with human disease; it has been associated with myelopathy but not with leukaemia (Dooneief et al., 1996; Harrington Jr. et al., 1993; Hjelle et al., 1992; Jacobson et al., 1993; Murphy et al., 1997; Sheremata et al., 1993). The majority (> 90%) of HTLV-I-infected persons are asymptomatic carriers, although there are some immunological differences in these carriers compared with healthy controls (see Section 5) (Robinson et al., 1994; Satoh et al., 1991).
First case of molecularly identified and genetically characterized human T-cell leukemia virus type 2 infection in a pregnant woman in non-endemic Japan
2021, Journal of Virological MethodsCitation Excerpt :Pathogenesis caused by HTLV‐2 infection is thought to be much rarer than pathogenesis due to infection with HTLV‐1, which can include ATL, HAM/TSP, or HTLV-1 uveitis (Mochizuki et al., 1992). Although it was reported that HTLV‐2 infection may be associated with hairy cell leukemia (Kalyanaraman et al., 1982) and a neurological disorder (Hjelle et al., 1992; Jacobson et al., 1993), these associations have not yet been clinically established. In fact, the woman reported herein was pregnant without hematological and neurological abnormalities at the time of writing (data not shown).
Human T lymphotropic virus (HTLV I and II) antibodies seroprevalence among organ donors
2020, Medicina IntensivaHuman T-Lymphotropic Virus (HTLV)
2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases